Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Reproducing human and cross-species drug toxicities using a Liver-Chip.

Jang KJ, Otieno MA, Ronxhi J, Lim HK, Ewart L, Kodella KR, Petropolis DB, Kulkarni G, Rubins JE, Conegliano D, Nawroth J, Simic D, Lam W, Singer M, Barale E, Singh B, Sonee M, Streeter AJ, Manthey C, Jones B, Srivastava A, Andersson LC, Williams D, Park H, Barrile R, Sliz J, Herland A, Haney S, Karalis K, Ingber DE, Hamilton GA.

Sci Transl Med. 2019 Nov 6;11(517). pii: eaax5516. doi: 10.1126/scitranslmed.aax5516.

PMID:
31694927
2.

Transmural unipolar electrogram change occurs within 7 s at the left atrial posterior wall during pulmonary vein isolation.

Tomlinson DR, Myles M, Stevens KN, Streeter AJ.

Pacing Clin Electrophysiol. 2019 Jul;42(7):922-929. doi: 10.1111/pace.13729. Epub 2019 Jun 10.

PMID:
31127636
3.

Adjusting for unmeasured confounding in nonrandomized longitudinal studies: a methodological review.

Streeter AJ, Lin NX, Crathorne L, Haasova M, Hyde C, Melzer D, Henley WE.

J Clin Epidemiol. 2017 Jul;87:23-34. doi: 10.1016/j.jclinepi.2017.04.022. Epub 2017 Apr 28. Review.

4.

Analysis of the variability of the pharmacokinetics of multiple drugs in young adult and elderly subjects and its implications for acceptable daily exposures and cleaning validation limits.

Streeter AJ, Faria EC.

Int J Hyg Environ Health. 2017 Jun;220(4):659-672. doi: 10.1016/j.ijheh.2017.03.007. Epub 2017 Mar 20. Review.

PMID:
28396010
5.

Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals.

Reichard JF, Maier MA, Naumann BD, Pecquet AM, Pfister T, Sandhu R, Sargent EV, Streeter AJ, Weideman PA.

Regul Toxicol Pharmacol. 2016 Aug;79 Suppl 1:S67-78. doi: 10.1016/j.yrtph.2016.05.027. Epub 2016 May 22. Review.

PMID:
27224509
6.

Anti-Müllerian hormone in children: a ten-year prospective longitudinal study (EarlyBird 39).

Jeffery A, Streeter AJ, Hosking J, Wilkin TJ, Nelson SM.

J Pediatr Endocrinol Metab. 2015 Sep;28(9-10):1153-62. doi: 10.1515/jpem-2014-0517.

PMID:
26030784
7.

Divergence between HbA1c and fasting glucose through childhood: implications for diagnosis of impaired fasting glucose (Early Bird 52).

Hosking J, Metcalf BS, Jeffery AN, Streeter AJ, Voss LD, Wilkin TJ.

Pediatr Diabetes. 2014 May;15(3):214-9.

PMID:
25705748
8.

Evidence of early beta-cell deficiency among children who show impaired fasting glucose: 10-yr cohort study (EarlyBird 56).

Hosking J, Metcalf BS, Jeffery AN, Streeter AJ, Voss LD, Wilkin TJ.

Pediatr Diabetes. 2013 Nov;14(7):481-9. doi: 10.1111/pedi.12049. Epub 2013 May 31.

PMID:
23721587
9.

Body fat in children does not adversely influence bone development: a 7-year longitudinal study (EarlyBird 18).

Streeter AJ, Hosking J, Metcalf BS, Jeffery AN, Voss LD, Wilkin TJ.

Pediatr Obes. 2013 Dec;8(6):418-27. doi: 10.1111/j.2047-6310.2012.00126.x. Epub 2013 Feb 28.

PMID:
23447431
10.

Age before stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26).

Jeffery AN, Metcalf BS, Hosking J, Streeter AJ, Voss LD, Wilkin TJ.

Diabetes Care. 2012 Mar;35(3):536-41. doi: 10.2337/dc11-1281. Epub 2012 Jan 25.

11.

The novel, orally active, delta opioid RWJ-394674 is biotransformed to the potent mu opioid RWJ-413216.

Codd EE, Carson JR, Colburn RW, Dax SL, Desai-Krieger D, Martinez RP, McKown LA, Neilson LA, Pitis PM, Stahle PL, Stone DJ, Streeter AJ, Wu WN, Zhang SP.

J Pharmacol Exp Ther. 2006 Sep;318(3):1273-9. Epub 2006 Jun 9.

PMID:
16766719
12.

Characterization of RWJ-351647, a novel nonpeptide vasopressin V2 receptor antagonist.

Gunnet JW, Matthews JM, Maryanoff BE, de Garavilla L, Andrade-Gordon P, Damiano B, Hageman W, Look R, Stahle P, Streeter AJ, Wines PG, Demarest KT.

Clin Exp Pharmacol Physiol. 2006 Apr;33(4):320-6.

PMID:
16620295
13.

Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase.

Shank RP, Doose DR, Streeter AJ, Bialer M.

Epilepsy Res. 2005 Feb;63(2-3):103-12.

PMID:
15715969
14.

Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis.

Markowska M, Oberle R, Juzwin S, Hsu CP, Gryszkiewicz M, Streeter AJ.

J Pharmacol Toxicol Methods. 2001 Jul-Aug;46(1):51-5.

PMID:
12164260
15.

Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.

Sachdeo RC, Sachdeo SK, Levy RH, Streeter AJ, Bishop FE, Kunze KL, Mather GG, Roskos LK, Shen DD, Thummel KE, Trager WF, Curtin CR, Doose DR, Gisclon LG, Bialer M.

Epilepsia. 2002 Jul;43(7):691-6. Erratum in: Epilepsia 2002 Oct;43(10):1273.

16.

Oral administration of cyclopentane neuraminidase inhibitors protects ferrets against influenza virus infection.

Sweet C, Jakeman KJ, Bush K, Wagaman PC, McKown LA, Streeter AJ, Desai-Krieger D, Chand P, Babu YS.

Antimicrob Agents Chemother. 2002 Apr;46(4):996-1004.

17.

An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.

Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE.

Epilepsia. 2000;41 Suppl 1:S3-9. Review.

18.

Pharmacokinetics and bioavailability of topiramate in the beagle dog.

Streeter AJ, Stahle PL, Holland ML, Pritchard JF, Takacs AR.

Drug Metab Dispos. 1995 Jan;23(1):90-3.

PMID:
7720530
19.

Denitrosation of N-nitrosodimethylamine in the rat in vivo.

Streeter AJ, Nims RW, Sheffels PR, Keefer LK.

Adv Exp Med Biol. 1991;283:371-5. No abstract available.

PMID:
2069010
20.

Carcinogenicity study of fecapentaene-12 diacetate on skin painting in SENCAR mice.

Devor DE, Henneman JR, Keefer LK, Logsdon DL, Rice JM, Streeter AJ, Ward JM.

Cancer Lett. 1991 Jan;56(1):11-5.

PMID:
2004349
21.

Toxicokinetic studies of N-nitrosamine carcinogenesis.

Streeter AJ, Nims RW, Keefer LK.

IARC Sci Publ. 1991;(105):362-5. No abstract available.

PMID:
1855881
22.

Deuterium isotope effect on the toxicokinetics of monomethylamine in the rat.

Streeter AJ, Nims RW, Sheffels PR, Hrabie JA, Ohannesian L, Heur YH, Mico BA, Keefer LK.

Drug Metab Dispos. 1990 Jul-Aug;18(4):447-52.

PMID:
1976066
23.

Pharmacokinetics of N-nitrodimethylamine and N-nitromethylamine in the rat.

Hassel M, Frei E, Streeter AJ, Wiessler M.

Carcinogenesis. 1990 Mar;11(3):357-60.

PMID:
2311177
24.

Metabolic denitrosation of N-nitrosodimethylamine in vivo in the rat.

Streeter AJ, Nims RW, Sheffels PR, Heur YH, Yang CS, Mico BA, Gombar CT, Keefer LK.

Cancer Res. 1990 Feb 15;50(4):1144-50.

25.

Single-dose toxicokinetics of N-nitrosomethylethylamine and N-nitrosomethyl (2,2,2-trideuterioethyl)amine in the rat.

Streeter AJ, Nims RW, Anderson LM, Heur YH, von Hofe E, Kleihues P, Nelson VC, Mico BA, Keefer LK.

Arch Toxicol. 1990;64(2):109-15.

PMID:
2350229
26.

Toxicokinetics of N-nitrosodimethylamine in the Syrian golden hamster.

Streeter AJ, Nims RW, Wu PP, Logsdon DL.

Arch Toxicol. 1990;64(7):562-6.

PMID:
2073129
27.

Investigations of the N-hydroxylation of 3'-hydroxyacetanilide, a non-hepatotoxic positional isomer of acetaminophen.

Rashed MS, Streeter AJ, Nelson SD.

Drug Metab Dispos. 1989 Jul-Aug;17(4):355-9.

PMID:
2571471
28.

The Fenton degradation as a nonenzymatic model for microsomal denitrosation of N-nitrosodimethylamine.

Heur YH, Streeter AJ, Nims RW, Keefer LK.

Chem Res Toxicol. 1989 Jul-Aug;2(4):247-53.

PMID:
2519780
29.

Decomposition and quality control considerations in biological work with fecapentaene preparations.

Streeter AJ, Donovan PJ, Anjo T, Ohannesian L, Sheffels PR, Wu PP, Keefer LK, Andrews AW, Bradford WW 3rd, Reist EJ, et al.

Chem Res Toxicol. 1989 May-Jun;2(3):162-8.

PMID:
2519720
30.

Sex differences in the single-dose toxicokinetics of N-nitrosomethyl(2-hydroxyethyl)amine in the rat.

Streeter AJ, Nims RW, Hrabie JA, Heur YH, Keefer LK.

Cancer Res. 1989 Apr 1;49(7):1783-9.

31.

Inactivity of fecapentaene-12 as a rodent carcinogen or tumor initiator.

Ward JM, Anjo T, Ohannesian L, Keefer LK, Devor DE, Donovan PJ, Smith GT, Henneman JR, Streeter AJ, Konishi N, et al.

Cancer Lett. 1988 Sep-Oct;42(1-2):49-59.

PMID:
3141039
32.
33.

Oxidative metabolites of 5-nitrofurans.

Streeter AJ, Krueger TR, Hoener BA.

Pharmacology. 1988;36(4):283-8.

PMID:
3380882
34.

Covalent binding of acetaminophen to mouse hemoglobin. Identification of major and minor adducts formed in vivo and implications for the nature of the arylating metabolites.

Axworthy DB, Hoffmann KJ, Streeter AJ, Calleman CJ, Pascoe GA, Baillie TA.

Chem Biol Interact. 1988;68(1-2):99-116.

PMID:
3203411
35.

Pharmacokinetic and deuterium isotope effect studies on the metabolism of formaldehyde and formate to carbon dioxide in rats in vivo.

Keefer LK, Streeter AJ, Leung LY, Perry WC, Hu HS, Baillie TA.

Drug Metab Dispos. 1987 May-Jun;15(3):300-4.

PMID:
2886303
36.

Cross-linking of protein molecules by the reactive metabolite of acetaminophen, N-acetyl-p-benzoquinone imine, and related quinoid compounds.

Streeter AJ, Harvison PJ, Nelson SD, Baillie TA.

Adv Exp Med Biol. 1986;197:727-37. No abstract available.

PMID:
3766291
37.

2-Acetamido-p-benzoquinone: a reactive arylating metabolite of 3'-hydroxyacetanilide.

Streeter AJ, Baillie TA.

Biochem Pharmacol. 1985 Aug 15;34(16):2871-6.

PMID:
4026876
38.

Identification of the major covalent adduct formed in vitro and in vivo between acetaminophen and mouse liver proteins.

Hoffmann KJ, Streeter AJ, Axworthy DB, Baillie TA.

Mol Pharmacol. 1985 May;27(5):566-73.

PMID:
3990678
39.

The in vitro metabolism of hydralazine.

Streeter AJ, Timbrell JA.

Drug Metab Dispos. 1985 Mar-Apr;13(2):255-9.

PMID:
2859177
40.

Structural characterization of the major covalent adduct formed in vitro between acetaminophen and bovine serum albumin.

Hoffmann KJ, Streeter AJ, Axworthy DB, Baillie TA.

Chem Biol Interact. 1985 Feb-Apr;53(1-2):155-72.

PMID:
3995650
41.

The microsomal metabolism and site of covalent binding to protein of 3'-hydroxyacetanilide, a nonhepatotoxic positional isomer of acetaminophen.

Streeter AJ, Bjorge SM, Axworthy DB, Nelson SD, Baillie TA.

Drug Metab Dispos. 1984 Sep-Oct;12(5):565-76.

PMID:
6149906
42.

The covalent binding of acetaminophen to protein. Evidence for cysteine residues as major sites of arylation in vitro.

Streeter AJ, Dahlin DC, Nelson SD, Baillie TA.

Chem Biol Interact. 1984 Mar;48(3):349-66.

PMID:
6713598
43.

Studies on the in vivo metabolism of hydralazine in the rat.

Streeter AJ, Timbrell JA.

Drug Metab Dispos. 1983 May-Jun;11(3):184-9.

PMID:
6135573
44.

Enzyme-mediated covalent binding of hydralazine to rat liver microsomes.

Streeter AJ, Timbrell JA.

Drug Metab Dispos. 1983 May-Jun;11(3):179-83.

PMID:
6135572
45.

Studies on hydrazine hepatotoxicity. 2. Biochemical findings.

Timbrell JA, Scales MD, Streeter AJ.

J Toxicol Environ Health. 1982 Dec;10(6):955-68.

PMID:
7161842
46.

Determination of hydralazine and its acetylated metabolites in urine by gas chromatography and high-pressure liquid chromatography.

Facchini V, Streeter AJ, Timbrell JA.

J Chromatogr. 1980 Jan 4;187(1):218-23. No abstract available.

PMID:
7358817
47.

The effect of dichloralphenazone pretreatment on paracetamol hepatotoxicity in mice.

Streeter AJ, Timbrell JA.

Biochem Pharmacol. 1979 Oct 1;28(19):3035-7. No abstract available.

PMID:
518701

Supplemental Content

Loading ...
Support Center